Who Owned Georgia English.pdf

the pharmaceutical market is ripe for investment and points tothat fact that Georgia has no pricing controls on pharmaceuticalsand no VAT is charged on pharmaceuticals and pharmaceuticalinputs.“Until now, the pharmaceutical retail market has longbeen perceived to operate with high pricing margins and withdomination by a small handful of players,” she wrote in anarticle for Investor.ge, the magazine of the American Chamber ofCommerce. “… some data has shown as much as 25% decreasesin pharmaceutical prices as a result of increased competition, 242 ”she adds, but this figure is misleading.The median unit price of medicines did decrease between2009 and 2011, especially for original brands, although, thisdecrease occurred only for 27% of the original brands and21% for the lowest price generics. The rest of the medicinesactually increased in price. In other words, three-fourths of themedicines on the market have become more expensive 243 . Oneexplanation for this could be that some groups of medicines aremore preferred, due to increasing import opportunities. Anotherexplanation is that the major distributors might have purposelypushed a group of medicines down to stimulate a positive imageof market development.A study by Curatio International Foundation (CIF) revealedthat Aversi, PSP and GPC have the highest decrease on originalbrands and the highest increase of lowest price generics. CIF says242 Investor.ge Issue 2, 2012. April-May http://www.investor.ge/article_2012_2.php?art=5 Accessed 05/12/2012243 Rationalization of Pharmaceutical Expenditures in Georgia, Partnership forSocial Initiatives. p.3 GotsadzeT. (2011) http://www.psidiscourse.ge/files/files/pdfs/Rationalization%20of%20the%20Pharmaceutical%20Expenditures%20in%20Georgia.pdf Accessed 05/12/201259